6.
Khalaveh F, Fazel N, Mischkulnig M, Vossen M, Reinprecht A, Dorfer C
. Risk Factors Promoting External Ventricular Drain Infections in Adult Neurosurgical Patients at the Intensive Care Unit-A Retrospective Study. Front Neurol. 2021; 12:734156.
PMC: 8631749.
DOI: 10.3389/fneur.2021.734156.
View
7.
Lass-Florl C, Kanj S, Govender N, Thompson 3rd G, Ostrosky-Zeichner L, Govrins M
. Invasive candidiasis. Nat Rev Dis Primers. 2024; 10(1):20.
DOI: 10.1038/s41572-024-00503-3.
View
8.
Southwick K, Ostrowsky B, Greenko J, Adams E, Lutterloh E, Denis R
. A description of the first Candida auris-colonized individuals in New York State, 2016-2017. Am J Infect Control. 2021; 50(3):358-360.
PMC: 9853438.
DOI: 10.1016/j.ajic.2021.10.037.
View
9.
Williamson R, Phillips-Bute B, McDonagh D, Gray M, Zomorodi A, Olson D
. Predictors of extraventricular drain-associated bacterial ventriculitis. J Crit Care. 2013; 29(1):77-82.
DOI: 10.1016/j.jcrc.2013.08.012.
View
10.
Sridharan S, Govindaswamy A, Rajendran A, Kumar V
. Challenges in management of Candida auris meningitis secondary to infected ventriculoperitoneal shunt - A case report. Indian J Med Microbiol. 2024; 48:100555.
DOI: 10.1016/j.ijmmb.2024.100555.
View
11.
Muralidharan R
. External ventricular drains: Management and complications. Surg Neurol Int. 2015; 6(Suppl 6):S271-4.
PMC: 4450504.
DOI: 10.4103/2152-7806.157620.
View
12.
Raja N
. Epidemiology, risk factors, treatment and outcome of Candida bloodstream infections because of Candida albicans and Candida non-albicans in two district general hospitals in the United Kingdom. Int J Clin Pract. 2020; 75(1):e13655.
DOI: 10.1111/ijcp.13655.
View
13.
Ramanan M, Shorr A, Lipman J
. Ventriculitis: Infection or Inflammation. Antibiotics (Basel). 2021; 10(10).
PMC: 8532926.
DOI: 10.3390/antibiotics10101246.
View
14.
van de Beek D, Drake J, Tunkel A
. Nosocomial bacterial meningitis. N Engl J Med. 2010; 362(2):146-54.
DOI: 10.1056/NEJMra0804573.
View
15.
Lin M, Carmeli Y, Zumsteg J, Flores E, Tolentino J, Sreeramoju P
. Prior antimicrobial therapy and risk for hospital-acquired Candida glabrata and Candida krusei fungemia: a case-case-control study. Antimicrob Agents Chemother. 2005; 49(11):4555-60.
PMC: 1280123.
DOI: 10.1128/AAC.49.11.4555-4560.2005.
View
16.
Papp Z, Borman A, Forgacs L, Kovacs R, Toth Z, Chun-Ju C
. Unpredictable In Vitro Killing Activity of Amphotericin B against Four Clades. Pathogens. 2021; 10(8).
PMC: 8398933.
DOI: 10.3390/pathogens10080990.
View
17.
Siopi M, Peroukidou I, Beredaki M, Spruijtenburg B, de Groot T, Meis J
. Overestimation of Amphotericin B Resistance in Candida auris with Sensititre YeastOne Antifungal Susceptibility Testing: a Need for Adjustment for Correct Interpretation. Microbiol Spectr. 2023; 11(3):e0443122.
PMC: 10269614.
DOI: 10.1128/spectrum.04431-22.
View
18.
Cavalheiro M, Teixeira M
. Biofilms: Threats, Challenges, and Promising Strategies. Front Med (Lausanne). 2018; 5:28.
PMC: 5816785.
DOI: 10.3389/fmed.2018.00028.
View
19.
Jones C, Neill C, Borman A, Budd E, Cummins M, Fry C
. The laboratory investigation, management, and infection prevention and control of : a narrative review to inform the 2024 national guidance update in England. J Med Microbiol. 2024; 73(5).
PMC: 11165919.
DOI: 10.1099/jmm.0.001820.
View
20.
Jarvis W
. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis. 1995; 20(6):1526-30.
DOI: 10.1093/clinids/20.6.1526.
View